1.
Preclinical investigations validate anticancer effects of alkyl-phospholipid perifosine against breast cancer cells. CRM [Internet]. 2026 Sep. 7 [cited 2026 Sep. 23];3(1):39-48. Available from: https://biologycircle.com/index.php/crm/article/view/87